Elanco Animal Health Inc. ELAN United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s united states — revenue?
- Elanco Animal Health Inc. (ELAN) reported united states — revenue of $605M in Q1 2026.
- How has Elanco Animal Health Inc.'s united states — revenue changed year-over-year?
- Elanco Animal Health Inc.'s united states — revenue increased by 9.2% year-over-year, from $554M to $605M.
- What is the long-term trend for Elanco Animal Health Inc.'s united states — revenue?
- Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s united states — revenue has grown at a 1.3% compound annual growth rate (CAGR), from $2.12B to $2.23B.
- What does united states — revenue mean?
- The total amount of money generated from sales of products in the United States.
- How do you interpret united states — revenue?
- An increase suggests successful product adoption or market expansion in the U.S., while a decrease may indicate competitive pressure or reduced demand for animal health solutions.
- How does united states — revenue compare across companies?
- Comparable to regional revenue segments reported by other global animal health or pharmaceutical companies.